Lucid Diagnostics Inc. (LUCD) Q2 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Lucid Diagnostics Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.522 Good morning and welcome to the Lucid Diagnostics second quarter 2025 00:00:05.522 -- 00:00:11.214 business update conference call. At this time, all lines are in listen-only 00:00:11.214 -- 00:00:15.884 mode. Following the presentation, we will conduct a question and answer session. 00:00:15.884 -- 00:00:20.972 If at any time during this call you require immediate assistance, please 00:00:20.972 -- 00:00:27.140 press star zero for the operator. Please note that this event is being recorded. 00:00:27.140 -- 00:00:32.527 I would now like to turn the conference over to Matt Riley, Lucid Diagnostics 00:00:32.527 -- 00:00:37.972 Senior Director of Investor Relations. Please go ahead. 00:00:38.656 -- 00:00:40.999 Thank you, operator, and good morning, everyone. 00:00:40.999 -- 00:00:44.294 Thank you for participating in today's business update call. 00:00:44.294 -- 00:00:49.679 Joining me today on the call are Dr. Elisha Nakhlog, Chairman and CEO of Lucid Diagnostics, 00:00:49.679 -- 00:00:52.702 along with Dennis McGrath, Chief Financial Officer. 00:00:52.702 -- 00:00:56.125 The press release announcing our business update and financial results is available on 00:00:56.125 -- 00:01:00.288 Lucid's website. Please take a moment to read the disclaimers about forward-looking statements 00:01:00.288 -- 00:01:04.352 in the press release. The business update, press release, and the conference call all 00:01:04.352 -- 00:01:07.995 include forward-looking statements, and these forward-looking statements are subject 00:01:07.995 -- 00:01:11.839 to known and unknown risks and uncertainties that may cause actual results to differ 00:01:11.839 -- 00:01:16.359 materially from the statements made. Factors that could cause actual results to differ 00:...